ANI Pharmaceuticals, Inc. (ANIP)
82.72
-0.05
(-0.06%)
USD |
NASDAQ |
May 22, 16:00
82.76
+0.04
(+0.05%)
After-Hours: 20:00
ANI Pharmaceuticals Total Liabilities (Quarterly) : 859.67M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Liquidia Corp. | 292.95M |
| Indivior Pharmaceuticals, Inc. | 1.341B |
| Phathom Pharmaceuticals, Inc. | 642.08M |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Assertio Holdings, Inc. | 135.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.422B |
| Shareholders Equity (Quarterly) | 562.30M |
| Debt to Equity Ratio | 1.092 |
| Current Ratio | 3.118 |
| Net Debt Paydown Yield | 0.40% |